A new Beginning..., page-34

First 34 Last

Share
Profile

Follow
investorgadget

42 Posts.

30/11/17

00:00

Post #: 29235788
Share

Originally posted by TerribleTadpole ↑

You just confirmed exactly what @investorgadget (and I) said, and in fact overturned your own statements earlier that "we won't be getting much news for another few months I expect"
and "not sure that we should expect IRB protocols to be announced"
and "all 3 hospitals are signed up to do the trial again"
and even "We are on track and looks like we will start the trial on time"

Resapp has on several occasions said variously that they
...intend to start the trials before the start of winter
...start earlier than last time
...release final results in April

In the overall scheme of things, this is probably no biggie. FDA approval when/if it comes is going to be a watershed event. And if it doesn't then there will be a sorry, flickering end to quite a few people's hopes.

But I believe none of you have any right at all to hang carp on @Gekkowolf and @investorgadget for raising this issue when they have quite correctly pointed out the discrepancy between the management's stated plan and what they have delivered. And if @Gekkowolf is very, very disappointed then he(?) has the right to say that too.

All I'm trying to say is that if somebody says something that is true, and you don't like what they said, at least have the bigness of spirit to acknowledge the truth of what they said before you start arguing about whether or not it's important.

Expand

I will point out I don't believe they are behind schedule, I actually anticipate all three in the next 2 weeks. MGH ethics Board meet every Friday from the research I could find - could be wrong though?

Also consider this. The US adult study could be over and done with in about 6 weeks, or about 4 times faster than the pediatric study - based on population numbers.

Last edited by investorgadget: 30/11/17

RAP Price at posting: 7.0¢ Sentiment: Hold Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

BRX

Belararox delineates another porphyry in Argentina at Tambo South

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

EMD

Emyria's Empax Centre chosen for mental health clinical trial

STX

Strike Energy secures $153 million for Perth Basin gas projects

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

FHE

Frontier Energy achieves key milestone for Waroona energy project

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

AML

Cultural heritage agreement puts Walford Creek exploration back on the map